Interference with clinical laboratory analyses.

Interference by endogenous and exogenous substances with assays for clinical analytes is a common problem in laboratory medicine. For this review, we defined interference as "the effect of a substance present in the sample that alters the correct value of the result, usually expressed as concentration or activity, for an analyte." There are four major endogenous compounds that consistently interfere with laboratory results: hemoglobin, bilirubin, lipids, and paraproteins. The major exogenous sources of interference are drugs prescribed for the patient; and there are several excellent compendia of the effect of drugs on clinical laboratory tests. We recommend determining whether the interference is dependent or independent of the analyte for the assay. Further, we propose an approach to the identification and resolution of an interference problem for the clinical laboratory and make recommendations to manufacturers.

[1]  G. Csako,et al.  Relevance of macro creatine kinase type 1 and type 2 isoenzymes to laboratory and clinical data. , 1994, Clinical chemistry.

[2]  M. Sampson,et al.  Effects of specimen turbidity and glycerol concentration on nine enzymatic methods for triglyceride determination. , 1994, Clinical chemistry.

[3]  D. Jay,et al.  Characterization and mathematical correction of hemolysis interference in selected Hitachi 717 assays. , 1993, Clinical chemistry.

[4]  D. Witte.  Matrix effects in therapeutic drug monitoring surveys. Proposed protocol to identify error components and quality improvement opportunities. , 1993, Archives of pathology & laboratory medicine.

[5]  L. Langman,et al.  Cross-reactivities of cyclosporin G (NVa2 cyclosporin) and metabolites in cyclosporin A immunoassays. , 1993, Clinical chemistry.

[6]  R Rej,et al.  Accurate enzyme activity measurements. Two decades of development in the commutability of enzyme quality control materials. , 1993, Archives of pathology & laboratory medicine.

[7]  F. Fonseca-Wollheim,et al.  Haemoglobin Interference in the Bichromatic Spectrophotometry of NAD(P)H at 340/380 nm , 1993 .

[8]  F. da Fonseca-Wollheim.  Haemoglobin interference in the bichromatic spectrophotometry of NAD(P)H at 340/380 nm. , 1993, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[9]  G. Cooper,et al.  Matrix effects and the accuracy of cholesterol analysis. , 1993, Archives of pathology & laboratory medicine.

[10]  W. Miller.  Matrix effects in the measurement and standardization of lipids and apolipoproteins , 1992 .

[11]  B. G. Blijenberg,et al.  Creatinine and Automatic Analysers in Relation to Icteric Specimens , 1992, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[12]  M. Kroll,et al.  Rationale for Using Multiple Regression Analysis with Complex Interferences , 1992, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[13]  M. Peake,et al.  Bicarbonate Interference with Hitachi Chloride Electrodes , 1991, Annals of clinical biochemistry.

[14]  M. Kroll.  Some observations on the reaction mechanism of cefoxitin and cephalothin with picrate , 1990 .

[15]  J. Gosling.  A decade of development in immunoassay methodology. , 1990, Clinical chemistry.

[16]  K. Emancipator,et al.  Bromide interference: is less really better? , 1990, Clinical chemistry.

[17]  J. Beilby,et al.  Interference by Haemolysis, Icterus and Lipaemia in Assays on the Beckman Synchron CX5 and Methods for Correction , 1990, Annals of clinical biochemistry.

[18]  J. Salway.  Drug-Test Interactions Handbook , 1990 .

[19]  S. Miyabo,et al.  Interference of Immunoglobulins in the Radioimmunoassay of Human β-Endorphin , 1990 .

[20]  R. Nussenblatt,et al.  Intravenous fluorescein interference with clinical laboratory tests. , 1989, American journal of ophthalmology.

[21]  S. Mendoza,et al.  Interference with creatinine concentration measurement by high dose furosemide infusion. , 1989, Critical care medicine.

[22]  M. Kroll,et al.  Effect of lyophilization on results of five enzymatic methods for cholesterol. , 1989, Clinical chemistry.

[23]  J. Greenson,et al.  The effect of hemolysis on creatine kinase determination. , 1989, Archives of pathology & laboratory medicine.

[24]  G. Schumann,et al.  Evaluierung der Ektachem-Single-Slide-Methode zur Bestimmung der Creatinin-Konzentration im Serum , 1989 .

[25]  O. Sonntag,et al.  Serum-Index und Interferogramm — Ein neuer Weg zur Prüfung und Darstellung von Interferenzen durch Serumchromogene , 1989 .

[26]  R. Romeo,et al.  Lidocaine metabolite and creatinine measurements in the Ektachem 700: steps to minimize its impact on patient care. , 1988, Clinical chemistry.

[27]  G. White,et al.  Evaluation of an enzymatic method for determining creatinine in plasma. , 1988, Journal of clinical pathology.

[28]  G. Siest,et al.  Drug effects on laboratory test results : analytical interferences and pharmacological effects , 1988 .

[29]  L. Boscato,et al.  Heterophilic antibodies: a problem for all immunoassays. , 1988, Clinical chemistry.

[30]  H. Schiller,et al.  Evaluation of lidocaine interference in the Kodak Ektachem 700 analyzer single-slide method for creatinine. , 1987, Clinical chemistry.

[31]  J. Coakley,et al.  Evaluation of single-slide creatinine method on the Kodak Ektachem 700 shows positive interference from lignocaine metabolites. , 1987, Clinical chemistry.

[32]  K. Opheim,et al.  Drug-specific Fab therapy in drug overdose. , 1987, Archives of pathology & laboratory medicine.

[33]  P. Kirkpatrick,et al.  Thyroid-function testing with the TDx: interference from endogenous fluorophore. , 1987, Clinical chemistry.

[34]  K. Ryder,et al.  Analytical systems ranked by freedom from interferences. , 1987, Clinical chemistry.

[35]  D. Blank,et al.  A model for assessing interference. , 1987, Clinical chemistry.

[36]  G. Siest,et al.  Drug interferences and drug effects in clinical chemistry. III: Evaluation of biological effects of drugs , 1987 .

[37]  N. Tamura,et al.  An immunoglobulin G inhibiting lactate dehydrogenase activity. , 1986, Clinica chimica acta; international journal of clinical chemistry.

[38]  M. Sonnenblick,et al.  Paraprotein interference with colorimetry of phosphate in serum of some patients with multiple myeloma. , 1986, Clinical chemistry.

[39]  L. Boscato,et al.  Incidence and specificity of interference in two-site immunoassays. , 1986, Clinical chemistry.

[40]  A. Wu,et al.  Bilirubin interference with determination of uric acid, cholesterol, and triglycerides in commercial peroxidase-coupled assays, and the effect of ferrocyanide. , 1986, Clinical chemistry.

[41]  K. Ryder,et al.  Graphical comparisons of interferences in clinical chemistry instrumentation. , 1986, Clinical chemistry.

[42]  G. F. Pierce,et al.  Interference by monoclonal proteins in the o-phthalaldehyde method for blood urea nitrogen. , 1986, Clinica chimica acta; international journal of clinical chemistry.

[43]  Guder Wg.  Haemolysis as an influence and interference factor in clinical chemistry. , 1986 .

[44]  O Sonntag,et al.  Haemolysis as an interference factor in clinical chemistry. , 1986, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[45]  K. Spencer.  Analytical Reviews in Clinical Biochemistry: The Estimation of Creatinine , 1986, Annals of clinical biochemistry.

[46]  W. Guder.  Haemolysis as an influence and interference factor in clinical chemistry. , 1986, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[47]  D. Blank,et al.  Hemoglobin interference from in vivo hemolysis. , 1985, Clinical chemistry.

[48]  R. Elin,et al.  Magnesium content of mononuclear blood cells. , 1985, Clinical chemistry.

[49]  M. Kroll,et al.  How certain drugs interfere negatively with the Jaffé reaction for creatinine. , 1985, Clinical chemistry.

[50]  C. Hagengruber,et al.  Reaction of picrate with creatinine and cepha antibiotics. , 1984, Clinical chemistry.

[51]  G. Drusano,et al.  Lack of interference with creatinine assays by four cephalosporin-like antibiotics. , 1984, American journal of clinical pathology.

[52]  M. Kroll,et al.  Mechanism of cefoxitin and cephalothin interference with the Jaffé method for creatinine. , 1983, Clinical chemistry.

[53]  A. Nanji,et al.  Antibody interference with biochemical tests and its clinical significance. , 1983, Clinical biochemistry.

[54]  J. Ladenson,et al.  Analytical Errors due to Lipemia , 1983 .

[55]  G. Siest,et al.  Drug effects on clinical laboratory tests. , 1983, Journal of pharmaceutical and biomedical analysis.

[56]  G. Drusano,et al.  Cefoxitin falsely elevates creatinine levels. , 1982, JAMA.

[57]  E. Nicholls.  Cephalothin interferes in automated assays of plasma creatinine. , 1981, Clinical chemistry.

[58]  E. A. Robertson,et al.  Bromide interferes with determination of chloride by each of four methods. , 1981, Clinical chemistry.

[59]  J. Lott,et al.  Serum enzymes and isoenzymes in the diagnosis and differential diagnosis of myocardial ischemia and necrosis. , 1980, Clinical chemistry.

[60]  D. Witte,et al.  Effects of bilirubin on detection of hydrogen peroxide by use of peroxidase. , 1978, Clinical chemistry.

[61]  B. Zak,et al.  Spectrophotometric study of bilirubin and hemoglobin interactions in several hydrogen peroxide generating procedures , 1978 .

[62]  G. Siest,et al.  Drug Interference in Clinical Chemistry: Studies on Ascorbic Acid , 1978, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[63]  B. Zak,et al.  Interesting interferences in a direct serum creatinine reaction , 1976 .

[64]  R. Laessig,et al.  The effects of 0.1 and 1.0 per cent erythrocytes and hemolysis on serum chemistry values. , 1976, American journal of clinical pathology.

[65]  Saris Ne.  Provisional recommendation on quality control in clinical chemistry. , 1977, Clinica chimica acta; international journal of clinical chemistry.

[66]  J. Lott,et al.  Evaluation of Trinder's glucose oxidase method for measuring glucose in serum and urine. , 1975, Clinical chemistry.

[67]  J. Ladenson,et al.  Patients as their own controls: use of the computer to identify "laboratory error". , 1975, Clinical chemistry.

[68]  A. Pakarinen,et al.  Effects of Drugs on Clinical Laboratory Tests , 1997, Annals of clinical biochemistry.

[69]  W. G. Brydon,et al.  The effect of haemolysis on the determination of plasma constituents. , 1972, Clinica chimica acta; international journal of clinical chemistry.

[70]  K. Larsen.  Creatinine assay by a reaction-kinetic principle. , 1972, Clinica chimica acta; international journal of clinical chemistry.

[71]  P. Munzenberger,et al.  The incidence of drug-diagnostic test interferences in outpatients. , 1971, American journal of hospital pharmacy.

[72]  W. Jencks.  Catalysis in chemistry and enzymology , 1969 .

[73]  P. Watkins.  The effect of ketone bodies on the determination of creatinine. , 1967, Clinica chimica acta; international journal of clinical chemistry.

[74]  W. T. Caraway.  Chemical and diagnostic specificity of laboratory tests. Effect of hemolysis, lipemia, anticoagulants, medications, contaminants, and other variables. , 1962, American journal of clinical pathology.

[75]  S. Meites,et al.  Direct spectrophotometry of total serum bilirubin in the newborn. , 1960, Clinical chemistry.

[76]  R. Carter,et al.  The effect of hemolysis on the van den Bergh reaction for serum bilirubin , 1960 .

[77]  R. J. Henry,et al.  On the determination of pancreatitis lipase in serum. , 1957, Clinical chemistry.